A day after one ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with more than $11 million worth of Pfizer Inc. (NYSE: PFE) shares, that fund was back at it on Wednesday. Specifically, it sold over 140,000 more shares, as the price of this ETF pulled back over 4% in the day’s session. However, it is up a fair amount in the past year.
[in-text-ad]
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 140,713 shares of Pfizer. At Wednesday’s closing price, this would have valued this sale at roughly $6.9 million. This is only a small fraction of the total holdings. The fund is up about 7% over the past 52 weeks.
Check out all the ARK Invest sales for Wednesday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKG | CLLS | CELLECTIS | 8,300 |
ARKG | PFE | PFIZER | 140,713 |
ARKG | REGN | REGENERON PHARMACEUTICALS | 11,602 |
ARKK | U | UNITY SOFTWARE | 113,490 |
ARKQ | U | UNITY SOFTWARE | 15,700 |
ARKW | U | UNITY SOFTWARE | 28,889 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
The Modern Investment App For a Richer Tomorrow (Sponsored)
Robinhood set out to democratize investing to individuals, and it’s not slowing down. The app makes it possible to buy and sell stocks, mutual funds, trade options, and even cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH).
With FDIC insurance ,an award winning design, and benefits like IRAs and more, Robinhood could be your path to a richer tomorrow.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.